Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CNXU Conexeu Sciences	$15.24 -4.8%	$0.00	$10.87 ▼ $18.79	$385.12M	N/A	103,889 shs	35,394 shs
COCH Envoy Medical	$0.66 -5.7%	$0.69	$0.36 ▼ $1.89	$50.83M	1.9	131,339 shs	96,975 shs
KIDS OrthoPediatrics	$18.32 +1.2%	$16.89	$14.42 ▼ $23.70	$470.55M	1.03	141,467 shs	83,242 shs
VANI Vivani Medical	$1.18 -7.8%	$1.20	$0.92 ▼ $1.92	$101.76M	2.31	191,185 shs	157,244 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CNXU Conexeu Sciences	-4.75%	+29.92%	+1,523,999,900.00%	+1,523,999,900.00%	+1,523,999,900.00%
COCH Envoy Medical	-5.68%	-6.28%	-2.13%	+1.64%	-54.08%
KIDS OrthoPediatrics	+1.22%	+6.70%	+7.01%	+1.50%	-8.95%
VANI Vivani Medical	-7.81%	-10.61%	-5.60%	+0.85%	+5.36%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CNXU Conexeu Sciences	$15.24 -4.8%	$0.00	$10.87 ▼ $18.79	$385.12M	N/A	103,889 shs	35,394 shs
COCH Envoy Medical	$0.66 -5.7%	$0.69	$0.36 ▼ $1.89	$50.83M	1.9	131,339 shs	96,975 shs
KIDS OrthoPediatrics	$18.32 +1.2%	$16.89	$14.42 ▼ $23.70	$470.55M	1.03	141,467 shs	83,242 shs
VANI Vivani Medical	$1.18 -7.8%	$1.20	$0.92 ▼ $1.92	$101.76M	2.31	191,185 shs	157,244 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CNXU Conexeu Sciences	-4.75%	+29.92%	+1,523,999,900.00%	+1,523,999,900.00%	+1,523,999,900.00%
COCH Envoy Medical	-5.68%	-6.28%	-2.13%	+1.64%	-54.08%
KIDS OrthoPediatrics	+1.22%	+6.70%	+7.01%	+1.50%	-8.95%
VANI Vivani Medical	-7.81%	-10.61%	-5.60%	+0.85%	+5.36%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CNXU Conexeu Sciences	0.00	N/A	N/A	N/A
COCH Envoy Medical	2.00	Hold	$2.50	278.10% Upside
KIDS OrthoPediatrics	2.82	Moderate Buy	$24.44	33.43% Upside
VANI Vivani Medical	2.00	Hold	$3.50	196.61% Upside

Current Analyst Ratings Breakdown

Latest VANI, COCH, CNXU, and KIDS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/1/2026	KIDS OrthoPediatrics	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$17.00
5/1/2026	KIDS OrthoPediatrics	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$24.00
4/24/2026	COCH Envoy Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
4/24/2026	KIDS OrthoPediatrics	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$25.00
4/21/2026	KIDS OrthoPediatrics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
4/1/2026	COCH Envoy Medical	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold
3/31/2026	COCH Envoy Medical	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$2.50
3/31/2026	VANI Vivani Medical	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$4.00 ➝ $3.50

(Data available from 6/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CNXU Conexeu Sciences	N/A	N/A	N/A	N/A	N/A	N/A
COCH Envoy Medical	$240K	211.80	N/A	N/A	($0.42) per share	-1.57
KIDS OrthoPediatrics	$236.35M	1.99	$0.17 per share	110.17	$13.82 per share	1.33
VANI Vivani Medical	N/A	N/A	N/A	N/A	$0.20 per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CNXU Conexeu Sciences	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
COCH Envoy Medical	-$23.76M	-$1.01	N/A	N/A	N/A	-9,875.64%	N/A	-177.92%	7/30/2026 (Estimated)
KIDS OrthoPediatrics	-$39.65M	-$1.68	N/A	N/A	N/A	-16.31%	-7.01%	-4.86%	8/4/2026 (Estimated)
VANI Vivani Medical	-$26.61M	-$0.40	N/A	N/A	N/A	N/A	-264.04%	-79.85%	8/12/2026 (Estimated)

Latest VANI, COCH, CNXU, and KIDS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/13/2026	Q1 2026	VANI Vivani Medical	-$0.08	-$0.08	N/A	-$0.08	N/A	N/A
5/11/2026	Q1 2026	COCH Envoy Medical	-$0.14	-$0.11	+$0.03	-$0.08	$0.10 million	$0.04 million
4/30/2026	Q1 2026	KIDS OrthoPediatrics	-$0.4552	-$0.42	+$0.0352	-$0.45	$58.29 million	$59.36 million
3/26/2026	Q4 2025	VANI Vivani Medical	-$0.10	-$0.09	+$0.01	-$0.09	N/A	N/A
3/23/2026	Q4 2025	COCH Envoy Medical	-$0.24	-$0.26	-$0.02	-$0.26	$0.03 million	$0.08 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CNXU Conexeu Sciences	N/A	N/A	N/A	N/A	N/A
COCH Envoy Medical	N/A	N/A	N/A	N/A	N/A
KIDS OrthoPediatrics	N/A	N/A	N/A	N/A	N/A
VANI Vivani Medical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CNXU Conexeu Sciences	N/A	N/A	N/A
COCH Envoy Medical	N/A	2.27	2.14
KIDS OrthoPediatrics	0.29	5.21	2.37
VANI Vivani Medical	N/A	3.18	3.18

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CNXU Conexeu Sciences	N/A
COCH Envoy Medical	8.59%
KIDS OrthoPediatrics	69.05%
VANI Vivani Medical	6.78%

Insider Ownership

Company	Insider Ownership
CNXU Conexeu Sciences	N/A
COCH Envoy Medical	7.10%
KIDS OrthoPediatrics	32.70%
VANI Vivani Medical	53.30%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CNXU Conexeu Sciences	4	25.27 million	N/A	N/A
COCH Envoy Medical	34	76.88 million	71.42 million	Not Optionable
KIDS OrthoPediatrics	200	25.68 million	17.29 million	Optionable
VANI Vivani Medical	20	86.24 million	40.27 million	Optionable

VANI, COCH, CNXU, and KIDS Headlines

Recent News About These Companies

Vivani Medical CEO Adam Mendelsohn to Present at the Jefferies Global Healthcare Conference on June 4, 2026

May 28, 2026 | markets.businessinsider.com

Vivani Medical (NASDAQ:VANI) Director Buys $1,999,999.26 in Stock

May 20, 2026 | insidertrades.com

Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update

May 13, 2026 | globenewswire.com

Vivani Medical (NASDAQ:VANI) Director Gregg Williams Purchases 1,587,301 Shares

April 17, 2026 | insidertrades.com

Williams Gregg buys Vivani medical (VANI) shares worth $1.99m

April 16, 2026 | investing.com

Vivani Medical (VANI) Upgraded to Buy: What Does It Mean for the Stock?

April 3, 2026 | zacks.com

Vivani Medical price target lowered to $3.50 from $4 at H.C. Wainwright

April 2, 2026 | finance.yahoo.com

Vivani Medical (VANI) price target increased by 10.00% to 5.61

March 28, 2026 | msn.com

Vivani completes first-in-human study of GLP-1 implant

March 27, 2026 | drugdeliverybusiness.comD

Vivani Medical, Inc. Advances NPM-139 Semaglutide Implant toward Phase 1 Clinical Study Following Successful LIBERATE-1 Trial and Positive Preclinical Data

March 26, 2026 | quiverquant.comQ

Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

March 26, 2026 | globenewswire.com

Vivani Medical (NASDAQ:VANI) Director Buys $1,685,497.17 in Stock

March 17, 2026 | insidertrades.com

Vivani medical director Williams buys shares worth $1.68 million

March 16, 2026 | investing.com

Vivani Medical Introduces Long-Acting Implant for GLP-1 Medications

March 3, 2026 | mddionline.comM

Williams Gregg buys Vivani medical (VANI) shares worth $1.98 million

February 17, 2026 | investing.com

Cortigent reports positive 6-year findings for brain implant for providing artificial vision

January 29, 2026 | massdevice.com

Vivani Subsidiary Cortigent Presents Promising 6-Year Early Feasibility Study Results for the Orion System at NANS 2026

January 29, 2026 | globenewswire.com

Vivani Medical (NASDAQ:VANI) Director Gregg Williams Buys 1,351,351 Shares

January 29, 2026 | insidertrades.com

Williams Gregg buys Vivani Medical (VANI) shares for $1.99m

January 28, 2026 | investing.com

Vivani Medical, Inc. Closes $4.5 Million Direct Offering and Private Placement to Support Clinical Development

January 27, 2026 | quiverquant.comQ

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

VANI, COCH, CNXU, and KIDS Company Descriptions

Conexeu Sciences NASDAQ:CNXU

$15.24 -0.76 (-4.75%)

Closing price 06/5/2026 03:58 PM Eastern

Extended Trading

$15.00 -0.24 (-1.57%)

As of 06/5/2026 07:39 PM Eastern

Conexeu is a company focused on building a new class of collagen-based regenerative tissue products. The Company was incorporated on November 2, 2022 under the Business Corporations Act (British Columbia) and was continued out of British Columbia and domesticated into the State of Nevada under the laws of the State of Nevada on April 10, 2025. --- Conexeu is an early-stage medical device company formed to acquire and commercialize intellectual property ("IP") developed over more than a decade at the University of British Columbia (the "University") and the BC Professional Firefighters Burn and Wound Healing Laboratory. In November 2023, the Company entered into a patent assignment agreement with the University pursuant to which the Company acquired an assignment of the University's right, title, and interest in the applicable patents and patent applications related to the underlying technology. The Company's only device candidate is the CXU™ scaffold device candidate, which is in preclinical development and has not been approved or cleared for marketing in any jurisdiction. The Company is conducting preclinical research and preparing for regulatory engagement to evaluate potential use in wound care and other medical applications. Any potential benefits to patients, providers, or healthcare systems have not been established and will require further study and regulatory review. CXU™ is a temperature-responsive, collagen-based extracellular matrix ("ECM") formulation designed to transition from a liquid to a gel-like scaffold following topical application or injection, typically within approximately ten minutes (the "10 Minute Tissue™" concept). The device IP is protected by issued and pending patents and is being evaluated in preclinical studies for its ability to provide an ECM-like environment associated with cellular infiltration, vascularization, and organized tissue remodeling in non-clinical models. We intend to seek U.S. Food and Drug Administration ("FDA") clearance in the United States for the CXU™ scaffold device candidate through the 510(k) premarket notification process as a Class II medical device; however, the FDA has not yet determined the appropriate classification or regulatory pathway for our device candidate, may require additional data or a different pathway, and there can be no assurance that we will obtain clearance or that the device candidate will become commercially available. Our principal executive offices are located in Reno, Nevada.

Envoy Medical NASDAQ:COCH

$0.66 -0.04 (-5.68%)

Closing price 06/5/2026 04:00 PM Eastern

Extended Trading

$0.66 0.00 (-0.33%)

As of 06/5/2026 04:10 PM Eastern

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

OrthoPediatrics NASDAQ:KIDS

$18.32 +0.22 (+1.22%)

Closing price 06/5/2026 04:00 PM Eastern

Extended Trading

$18.34 +0.02 (+0.11%)

As of 06/5/2026 05:55 PM Eastern

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Vivani Medical NASDAQ:VANI

$1.18 -0.10 (-7.81%)

Closing price 06/5/2026 04:00 PM Eastern

Extended Trading

$1.20 +0.02 (+1.69%)

As of 06/5/2026 07:24 PM Eastern

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest VANI, COCH, CNXU, and KIDS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest VANI, COCH, CNXU, and KIDS Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

VANI, COCH, CNXU, and KIDS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

VANI, COCH, CNXU, and KIDS Company Descriptions

Conexeu Sciences NASDAQ:CNXU

Envoy Medical NASDAQ:COCH

OrthoPediatrics NASDAQ:KIDS

Vivani Medical NASDAQ:VANI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest VANI, COCH, CNXU, and KIDS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest VANI, COCH, CNXU, and KIDS Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

VANI, COCH, CNXU, and KIDS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

VANI, COCH, CNXU, and KIDS Company Descriptions

Conexeu Sciences NASDAQ:CNXU

Envoy Medical NASDAQ:COCH

OrthoPediatrics NASDAQ:KIDS

Vivani Medical NASDAQ:VANI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools